Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thripthy Chandran"'
Autor:
Prathap Nagaraja Shastri, Lakshmi Prasanna Kolluru, Syed A. A. Rizvi, Martin J. D'Souza, Thripthy Chandran
Publikováno v:
Journal of Nanoparticle Research. 22
The present study describes the preparation, characterization, and applications of newly developed polymeric poly-ɛ-caprolactone (PCL)/pluronic F108 nanoparticles, loaded with anticancer drug, and near infrared (NIR) dye for assessing the localizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0430db411db547232d856ca3a803557
https://doi.org/10.1007/s11051-020-05096-y
https://doi.org/10.1007/s11051-020-05096-y
Publikováno v:
International Journal of Pharmaceutics. 419:281-286
The aim of this study was to develop micellar nanocarriers for concomitant delivery of paclitaxel and 17-allylamino-17-demethoxygeldanamycin (17-AAG) for cancer therapy. Paclitaxel and 17-AAG were simultaneously loaded into polymeric micelles by a so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a395a0229f481a34990065d1baf3b875
https://doi.org/10.1016/j.ijpharm.2011.07.033
https://doi.org/10.1016/j.ijpharm.2011.07.033
Publikováno v:
Nanoparticulate Vaccine Delivery Systems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efc38b942b11dda062527ec2090eb065
https://doi.org/10.1201/b18096-3
https://doi.org/10.1201/b18096-3
Publikováno v:
International journal of pharmaceutics. 392(1-2)
17-Allyamino-17-demethoxygeldanamycin (17-AAG) is a potent anticancer agent currently undergoing phases I and II clinical trials. However, the clinical development of 17-AAG has been hindered by its poor aqueous solubility and hepatotoxicity. This st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a191a79b4841c483ff724bc405c57971
https://pubmed.ncbi.nlm.nih.gov/20363305
https://pubmed.ncbi.nlm.nih.gov/20363305